ArticleChild's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery2026
Suprasellar CNS germ cell tumors and endocrine sequelae: early growth hormone therapy as a contributor to height gain: a single institute analysis.
Article in Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAlthough the prognosis of patients with pediatric intracranial germ cell tumors (ICGCTs) has improved, late effects in long-term survivors remains an important issue. Here, we evaluated endocrine complications and quality of life in ICGCT patients treated with proton beam therapy (PBT) or photon radiotherapy (RT).
methodsWe retrospectively evaluated 18 patients aged 15 years or younger at the time of ICGCT diagnosis at University of Tsukuba Hospital from January 2010 to December 2016.
resultsEleven had tumors in the suprasellar region and seven in other parts of the brain (non-suprasellar ICGCT). Ten were treated with proton beam therapy only in combination with chemotherapy. All but 2 patients were alive without disease. The number of cases receiving hormone replacement therapy (HRT) were significantly higher in the suprasellar tumor group (p < 0.001), and longer time to diagnosis (TTD) from onset was associated with the number of hormones being replaced at the last visit (correlation coefficient 0.77, p < 0.001). All the patients who received appropriate growth hormone therapy increased in height without relapse of the tumor. With regard to the modality of radiation therapy for ICGCTs, PBT was equivalent to photon RT in terms of recurrence, survival, number of hormones being replaced, and quality of life.
conclusionsHRT was more frequently administered to patients with suprasellar ICGCT than to those with non-suprasellar ICGCT, and was more likely to be required in patients with a longer TTD. Parameters such as radiotherapy and chemotherapy were not associated with HRT in survivors of ICGCTs.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.